Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,059 public trials 1,846 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

NCT06074588

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Hematology/Oncology - Santa Monica ( Site 0023) Los Angeles, California, United States
  • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0001) Jacksonville, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 0005) Orange City, Florida, United States
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0003) Marietta, Georgia, United States
View all 195 locations
View Trial Details
Active, not recruiting

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

NCT05853575

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • Local Institution - 101 Santa Rosa, California, United States
  • Local Institution - 105 Kansas City, Missouri, United States
  • Local Institution - 100 Durham, North Carolina, United States
  • Local Institution - 106 Dallas, Texas, United States
View all 98 locations
View Trial Details
Active, not recruiting

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

NCT06120075

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Grand Rapids, Michigan, United States
View Trial Details
Active, not recruiting

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

NCT06007937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering West Harrison (All Protocol Activities) Harrison, New York, United States
View Trial Details
Active, not recruiting

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

NCT02971501

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +16 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 18 locations
View Trial Details
Active, not recruiting

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

NCT05671510

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • XCancer/Dothan Hematology & Oncology - 1114 Dothan, Alabama, United States
  • Genesis Cancer and Blood Institute - 1123 Russellville, Arkansas, United States
  • The Oncology Institute (TOI) Clinical Research - 1109 Cerritos, California, United States
  • Emad Ibrahim MD Inc. - 1147 Redlands, California, United States
View all 152 locations
View Trial Details
Active, not recruiting

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

NCT04603807

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Oncocentro Serviços Médicos e Hospitalares Ltda Fortaleza, Ceará, Brazil
  • Hospital Sao Rafael - HSR Salvador, Estado de Bahia, Brazil
  • Hospitais Integrados da Gavea S/A Brasília, Federal District, Brazil
  • Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN Florianópolis, Santa Catarina, Brazil
View all 61 locations
View Trial Details

Related conditions